Patent details

Basic Information

Publication number:

EP1399127

PCT Application Number:

PCT/US/2002/019417

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP027375393

PCT Publication Number:

WO/2003/002093

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

OLOPATADINE FORMULATIONS FOR TOPICAL ADMINISTRATION

French Title of Invention:

FORMULATIONS D'OLOPATADINE A ADMINISTRATION TOPIQUE

German Title of Invention:

ZUBEREITUNGEN MIT OLOPATADIN ZUR TOPISCHEN ANWENDUNG

SPC Number:

Dates

Filing date:

19/06/2002

Grant date:

11/05/2005

EP Publication Date:

11/05/2005

PCT Publication Date:

09/01/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/03/2004

EP B1 Publication Date:

11/05/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

19/06/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2019

 

 

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

History of Owners

From:

12/12/2019

To:

12/12/2019

Name:

Alcon Pharmaceuticals Ltd.

Address:

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (CH)

From:

12/12/2019

To:

12/12/2019

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

From:

01/12/2005

To:

12/12/2019

Name:

Alcon Inc.

Address:

Bösch 69, 6331 Hünenberg, Switzerland (CH)

Inventor

1

Name:

HAN Wesley, Wehsin

Address:

United States (US)

2

Name:

ZHANG Huixiang

Address:

United States (US)

3

Name:

CASTILLO Ernesto, J.

Address:

United States (US)

4

Name:

DIXIT Suresh, C.

Address:

United States (US)

5

Name:

BULLOCK Joseph, Paul

Address:

United States (US)

6

Name:

SINGH Onkar, N.

Address:

United States (US)

7

Name:

BHAGAT Haresh, G.

Address:

United States (US)

Priority

Priority Number:

301315 P

Priority Date:

27/06/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000459A

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Fusion-Absorption

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000459B

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Alcon Pharmaceuticals Ltd.

Address:

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (CH)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000459C

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/06/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
24/12/2019	Outgoing Correspondence	1
12/12/2019	Request For Change	16